@EmKSims

Physician scientist at Indiana University

 Indianapolis, IN
Joined June 2018
  • Tweets358
  • Following170
  • Followers683
42Media
👋Meet us in #Indianapolis for our Complimentary CE Dinner Meeting on #Type1Diabetes on Monday, June 17th! ➡️ ow.ly/qakt50SelC2 @EmKSims #Diabetes #ContinuingEducation #HealthcareProfessionals #Continuingprofessionaleducation #FOAMed #endocrinology
1
290
Congrats to the global experts recognized as 2024 @WIELDvoice Trailblazers, especially @IUMedSchool Drs. Evans-Molina & DiMeglio and @EliLillyandCo Dr. Gimeno. We're proud and fortunate to have many female leaders in diabetes making an impact in Indiana! womenleadingdiabetes.com/dia…
1
3
2
21
1,850
Attending #nPOD2024! Come to our @WIELDvoice breakfast panel where we discuss opportunities & barriers to leadership.
Women Inspiring & Elevating Leadership in Diabetes@WIELDvoice22 Jan 2024
Attending nPOD (npod.org/agenda/)? Then attend our breakfast panel on barriers to leadership as well! #nPOD2024 @LinnemannLab @rmirmira @jessdunnephd @gFousteri @TseHubert @DiabetesnPOD
6
12
2,379
This was a very fun project to work on. I'd like to congratulate the whole team, in special Milene Vallejo (not on Twitter) for the hard work. @smpowell16 @byu_sam @EmKSims @MirmiraLab @rmirmira @uabmedicine @BYU @IUSweetTweets @sciencePNNL @OmicsPNNL @UChicagoMed (6/n)
1
1
4
818
New from @JanelKopp ‘s lab and mine, and the final paper from our shared student @annizubc ‘s ground breaking PhD thesis. Happy to co publish with @LupoCiyuCy who has a complementary story in breast cancer in Cell Reports.
Cell Metabolism@Cell_Metabolism31 Oct 2023
New! Online now: Hyperinsulinemia acts via acinar insulin receptors to initiate pancreatic cancer by increasing digestive enzyme production and inflammation dlvr.it/SyC3xz
4
31
2
123
13,935
We are #hiring an academic lab technician! My lab researches diabetes and genetic disease using molecular biology techniques and animal models. We would love you to join our team! Job details below (JOBS.IU ID 308789). DM for more information. Please RT. hrms.indiana.edu/psc/PH1PRD_…

Jobs at IU

Find your place at Indiana University. Explore faculty and staff positions on our seven campuses for a healthy, enriching, and balanced work life.

hrms.indiana.edu
10
2
22
5,506
📈 OUT NOW @CommsMedicine - Felton et al. review the evidence on disease-modifying therapies & features linked to treatment response in #T1D prevention | @emksims @jamielfelton @RAOram @catespeake @ssr4n @cevansmo @DOctorDiMeglio @Heba_T1D @randikjohnson nature.com/articles/s43856-0…

Disease-modifying therapies and features linked to treatment response in type 1 diabetes preventi...

Communications Medicine - Felton et al. conducted a systematic review to evaluate studies testing disease-modifying therapies and features linked to treatment response for type 1 diabetes...

nature.com
7
11
1,591
🗞️NEWS: #EASD session explores whether universal screening for type 1 #diabetes is around the corner Read more➡️ bit.ly/3rJs4i3 #EASD2023
1
2
2
384
To start urgent steroids or not to start urgent steroids, that is THE question in acute #opticneuritis. So proud of the hard work of talented @ExeterMed student Pavel Loginovic, presenting today at #MSfrontiers22, inching us closer to an individualised answer for our patients
3
6
2
31
New publication from the lab!! Congratulations to @danilou1005 — this is a great review of the literature in the area of exocrine-endocrine crosstalk. So much we don’t know — but the field is moving in exciting directions! #crosstalk #pancreas frontiersin.org/articles/10.…
5
17
3
74
Thanks again for the opportunity to discuss our work on beta cell senescence in #T1D @IUSweetTweets and meet with faculty and trainees! Looking forward to seeing you at in-person meetings soon @LinnemannLab @spaeth_jason @prof_templin @cevansmo @EmKSims @TeresaMastracci
1
1
17
The time has come to consider general population screening for #T1D risk. Our #TrialNet perspectives piece published in Diabetes provides a status report and addresses remaining implementation hurdles @EmKSims @IUSweetTweets @IUWellsCenter @YaleMed bit.ly/3tA4hz8

Screening for Type 1 Diabetes in the General Population: A Status Report and Perspective

Most screening programs to identify individuals at risk for type 1 diabetes have targeted relatives of people living with the disease to improve yield and

diabetesjournals.org
10
2
19
Emily K. Sims retweeted
Gabriel Bosslet@gbosslet29 Dec 2021
If there were restaurants in Indiana that required proof of vaccination and all employees were vaccinated I would go to those places exclusively. Retweet if you agree so business owners will see how many of us there are. #hoosiertwitter
66
558
45
1,176
Why is widespread screening for type 1 diabetes crucial? Check out the WWDA’s newest blog post, “Five Things to Know About Type 1 Diabetes Screening,” where I share my thoughts on the importance of T1D screening and new Janssen screening programs: lnkd.in/gWjYXH3N #T1D
5
17
More than 1/2 of newly diagnosed #T1D are adults, but T1D often gets misdiagnosed or undiagnosed, leading to practical challenges. Here, we discuss our current understanding of adult-onset T1D and practical solutions to improve. ⁩ care.diabetesjournals.org/co…
1
13
37
Delighted to share our new preprint from the @BruceVerchere lab. We showed that plasma PI/C ratio is a good predictive indicator of insulin dependency in autologous pancreatic islet transplant recipients. (1/3) biorxiv.org/content/10.1101/…

Elevated islet prohormone ratios as indicators of insulin dependency in islet transplant recipients

Autologous pancreatic islet transplantation is an established therapy for patients with chronic pancreatitis. However, the long-term transplant outcomes are modest. Identifying indicators of graft...

biorxiv.org
4
17
38
Delighted to work with a great group of coauthors on this project led by @jamielfelton focused on identifying simple metabolic measures that can help stratify TID risk. A big thank you to @T1D_TrialNet study participants!
Diabetologia@DiabetologiaJnl19 Oct 2021
HOMA2-B, a single-time-point measurement, is associated with type 1 diabetes risk in individuals with established #autoimmunity followed in #TrialNet. #T1D @IUSweetTweets @T1D_TrialNet @JamieLFelton @cevansmo
7
3
43
ICYMI at #ADA2021: Six early-career scientists showcase their @niddkgov-supported research. Read a recap: ow.ly/mdlv30rSEnL @EmilynAlejandro @emksims @deltacells @naylorrochelle @cepowemd @joshuajosephmd
3
7
Replying to @IUMedSchool
@IUMedSchool authors @EmKSims,@cevansmo, and @DoctorDiMeglio worked w/ @ExeterMed colleagues @RAOram and @alicelouisejane on this @NatureMedicine review. In it, they commemorate the #Insulin100 milestone and highlight the experiences of the #T1D community.
Exeter Med School@ExeterMed28 Jul 2021
We reflect with @IUMedSchool on #diabetes research 100 yrs after discovery of #insulin. Our PhD researcher Alice Carr has #type1: "These stories reminded me that I share the same pains and triumphs with a resilient bunch of ppl that span the globe." More: medicine.exeter.ac.uk/news/a…
3
6
Replying to @IUMedSchool
@IUMedSchool's Dr. Emily Sims (@EmKSims) has been named the Assistant Director of Faculty Development and Translational Research here at the Wells Center! Find out about Dr. Sims' work, her hopes for this new role and her go-to karaoke jam 👇👇👇 medicine.iu.edu/blogs/pediat…

Meet Emily K. Sims, newly named Wells Center assistant director

Emily K. Sims, MD, has been named with Assistant Director of Faculty Development and Translational Research at the Herman B Wells Center for Pediatric Research.

medicine.iu.edu
2
3
8
Load more